|
Volumn 16, Issue 2, 2014, Pages 245-
|
Treatment of obstructive sleep apnoea improves metabolic conditions and prevents initiation of antiarrhythmic therapy in a patient with atrial fibrillation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
ADULT;
ANAMNESIS;
APNEA HYPOPNEA INDEX;
CARDIAC PATIENT;
CARDIOVERSION;
CASE REPORT;
DAYTIME SOMNOLENCE;
DISEASE SEVERITY;
ELECTROCARDIOGRAM;
EPWORTH SLEEPINESS SCALE;
HEART ATRIUM FIBRILLATION;
HOLTER MONITORING;
HUMAN;
MALE;
METABOLIC SYNDROME X;
METABOLISM;
MIDDLE AGED;
NIGHT;
NOTE;
OXYGEN DESATURATION;
PAROXYSMAL HEART ATRIUM FIBRILLATION;
POSITIVE END EXPIRATORY PRESSURE;
PRIORITY JOURNAL;
RECURRENT DISEASE;
SLEEP DISORDERED BREATHING;
SUPRAVENTRICULAR PREMATURE BEAT;
ANTI-ARRHYTHMIA AGENTS;
ATRIAL FIBRILLATION;
ATRIAL PREMATURE COMPLEXES;
CONTINUOUS POSITIVE AIRWAY PRESSURE;
ELECTROCARDIOGRAPHY, AMBULATORY;
HUMANS;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
PREDICTIVE VALUE OF TESTS;
RECURRENCE;
RISK FACTORS;
SEVERITY OF ILLNESS INDEX;
SLEEP APNEA, OBSTRUCTIVE;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84893284028
PISSN: 10995129
EISSN: 15322092
Source Type: Journal
DOI: 10.1093/europace/eut233 Document Type: Note |
Times cited : (1)
|
References (0)
|